or
forgot password

    • cancer clinical trials in ottawa, IL

    • S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Community Hospital of Ottawa

    Trial Locations
    Community Hospital of Ottawa
    Oncology Hematology Associates of Central Illinois, PC - Ottawa
    Melanoma (Skin)
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Oncology Hematology Associates of Central Illinois, PC - Ottawa
    Ottawa, Illinois 61350
    Breast Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    Community Hospital of Ottawa

    Trial Locations
    Community Hospital of Ottawa
    Oncology Hematology Associates of Central Illinois, PC - Ottawa
    Lymphoma
    S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
    Community Hospital of Ottawa

    Trial Locations
    Community Hospital of Ottawa
    Oncology Hematology Associates of Central Illinois, PC - Ottawa
    Lymphoma
    Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Illinois CancerCare-Ottawa Clinic

    Trial Locations
    Illinois CancerCare-Ottawa Clinic
    Ottawa Regional Hospital and Healthcare Center
    Adult Acute Lymphoblastic Leukemia in Remission
    Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
    Illinois CancerCare-Ottawa Clinic

    Trial Locations
    Illinois CancerCare-Ottawa Clinic
    Ottawa Regional Hospital and Healthcare Center
    Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain Tumor
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Community Hospital of Ottawa

    Trial Locations
    Community Hospital of Ottawa
    Oncology Hematology Associates of Central Illinois, PC - Ottawa
    Endometrial Cancer
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Ottawa Regional Hospital and Healthcare Center
    Ottawa, Illinois 61350
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Community Hospital of Ottawa

    Trial Locations
    Community Hospital of Ottawa
    Oncology Hematology Associates of Central Illinois, PC - Ottawa
    Breast Cancer
    Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
    Community Hospital of Ottawa

    Trial Locations
    Community Hospital of Ottawa
    Oncology Hematology Associates of Central Illinois, PC - Ottawa
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    Community Hospital of Ottawa

    Trial Locations
    Community Hospital of Ottawa
    Oncology Hematology Associates of Central Illinois, PC - Ottawa
    Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Illinois CancerCare-Ottawa Clinic

    Trial Locations
    Illinois CancerCare-Ottawa Clinic
    Ottawa Regional Hospital and Healthcare Center
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
    Community Hospital of Ottawa

    Trial Locations
    Community Hospital of Ottawa
    Oncology Hematology Associates of Central Illinois, PC - Ottawa
    Leukemia
    Bortezomib, Paclitaxel, and Carboplatin Combined With Radiation Therapy in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    Illinois CancerCare-Ottawa Clinic

    Trial Locations
    Illinois CancerCare-Ottawa Clinic
    Ottawa Regional Hospital and Healthcare Center
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Ottawa Regional Hospital and Healthcare Center
    Ottawa, Illinois 61350
    Recurrent Mantle Cell Lymphoma
    Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
    Community Hospital of Ottawa
    Ottawa, Illinois 61350
    Multiple Myeloma and Plasma Cell Neoplasm
    Rituximab and Galiximab in Treating Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma
    Community Hospital of Ottawa

    Trial Locations
    Community Hospital of Ottawa
    Oncology Hematology Associates of Central Illinois, PC - Ottawa
    Lymphoma
    Lenalidomide and Prednisone in Treating Patients With Myelofibrosis
    Community Hospital of Ottawa

    Trial Locations
    Community Hospital of Ottawa
    Oncology Hematology Associates of Central Illinois, PC - Ottawa
    Chronic Myeloproliferative Disorders
    Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
    Illinois CancerCare-Ottawa Clinic

    Trial Locations
    Illinois CancerCare-Ottawa Clinic
    Ottawa Regional Hospital and Healthcare Center
    Stage I Bladder Cancer, Stage II Bladder Cancer, Stage III Bladder Cancer, Transitional Cell Carcinoma of the Bladder
    Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma
    Community Hospital of Ottawa

    Trial Locations
    Community Hospital of Ottawa
    Oncology Hematology Associates of Central Illinois, PC - Ottawa
    Lymphoma
    Bortezomib After Combination Chemotherapy, Rituximab, and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
    Community Hospital of Ottawa

    Trial Locations
    Community Hospital of Ottawa
    Oncology Hematology Associates of Central Illinois, PC - Ottawa
    Lymphoma
    Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
    Illinois CancerCare-Ottawa Clinic

    Trial Locations
    Illinois CancerCare-Ottawa Clinic
    Ottawa Regional Hospital and Healthcare Center
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Untreated Adult Acute Myeloid Leukemia